Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates
- PMID: 7639807
- DOI: 10.1002/art.1780380813
Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates
Abstract
Objective: To determine the following: 1) whether dietary supplementation with fish oil will allow the discontinuation of nonsteroidal antiinflammatory drugs (NSAIDs) in patients with rheumatoid arthritis (RA); 2) the clinical efficacy of high-dose dietary omega 3 fatty acid fish oil supplementation in RA patients; and 3) the effect of fish oil supplements on the production of multiple cytokines in this population.
Methods: Sixty-six RA patients entered a double-blind, placebo-controlled, prospective study of fish oil supplementation while taking diclofenac (75 mg twice a day). Patients took either 130 mg/kg/day of omega 3 fatty acids or 9 capsules/day of corn oil. Placebo diclofenac was substituted at week 18 or 22, and fish oil supplements were continued for 8 weeks (to week 26 or 30). Serum levels of interleukin-1 beta (IL-1 beta), IL-2, IL-6, and IL-8 and tumor necrosis factor alpha were measured by enzyme-linked immunosorbent assay at baseline and during the study.
Results: In the group taking fish oil, there were significant decreases from baseline in the mean (+/- SEM) number of tender joints (5.3 +/- 0.835; P < 0.0001), duration of morning stiffness (-67.7 +/- 23.3 minutes; P = 0.008), physician's and patient's evaluation of global arthritis activity (-0.33 +/- 0.13; P = 0.017 and -0.38 +/- 0.17; P = 0.036, respectively), and physician's evaluation of pain (-0.38 +/- 0.12; P = 0.004). In patients taking corn oil, no clinical parameters improved from baseline. The decrease in the number of tender joints remained significant 8 weeks after discontinuing diclofenac in patients taking fish oil (-7.8 +/- 2.6; P = 0.011) and the decrease in the number of tender joints at this time was significant compared with that in patients receiving corn oil (P = 0.043). IL-1 beta decreased significantly from baseline through weeks 18 and 22 in patients consuming fish oil (-7.7 +/- 3.1; P = 0.026).
Conclusion: Patients taking dietary supplements of fish oil exhibit improvements in clinical parameters of disease activity from baseline, including the number of tender joints, and these improvements are associated with significant decreases in levels of IL-1 beta from baseline. Some patients who take fish oil are able to discontinue NSAIDs without experiencing a disease flare.
Similar articles
-
Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects.Arthritis Rheum. 1990 Jun;33(6):810-20. doi: 10.1002/art.1780330607. Arthritis Rheum. 1990. PMID: 2363736 Clinical Trial.
-
n-3 fatty acid supplements in rheumatoid arthritis.Am J Clin Nutr. 2000 Jan;71(1 Suppl):349S-51S. doi: 10.1093/ajcn/71.1.349s. Am J Clin Nutr. 2000. PMID: 10617995 Review.
-
Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study.Ann Intern Med. 1987 Apr;106(4):497-503. doi: 10.7326/0003-4819-106-4-497. Ann Intern Med. 1987. PMID: 3030173 Clinical Trial.
-
Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis.Rheumatol Int. 2003 Jan;23(1):27-36. doi: 10.1007/s00296-002-0234-7. Epub 2002 Sep 6. Rheumatol Int. 2003. PMID: 12548439 Clinical Trial.
-
Dietary n-3 fatty acids and therapy for rheumatoid arthritis.Semin Arthritis Rheum. 1997 Oct;27(2):85-97. doi: 10.1016/s0049-0172(97)80009-1. Semin Arthritis Rheum. 1997. PMID: 9355207 Review.
Cited by
-
Role of specialized pro-resolving mediators on inflammation, cardiometabolic health, disease progression, and quality of life after omega-3 PUFA supplementation and aerobic exercise training in individuals with rheumatoid arthritis: a randomized 16-week, placebo-controlled interventional trial.F1000Res. 2023 Aug 7;12:942. doi: 10.12688/f1000research.138392.1. eCollection 2023. F1000Res. 2023. PMID: 38778807 Free PMC article. Clinical Trial.
-
Wünderlich's syndrome in a haemodialysis patient.BMJ Case Rep. 2023 Oct 10;16(10):e255985. doi: 10.1136/bcr-2023-255985. BMJ Case Rep. 2023. PMID: 37816578
-
Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis.Prostaglandins Leukot Essent Fatty Acids. 2023 Mar;190:102542. doi: 10.1016/j.plefa.2023.102542. Epub 2023 Jan 26. Prostaglandins Leukot Essent Fatty Acids. 2023. PMID: 36773395 Free PMC article.
-
Therapeutic Use of Omega-3 Fatty Acids for Immune Disorders In Search of the Ideal Omega-3 Supplement.Integr Med (Encinitas). 2022 Nov;21(5):14-18. Integr Med (Encinitas). 2022. PMID: 36643210 Free PMC article.
-
Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.Arthritis Res Ther. 2022 May 7;24(1):100. doi: 10.1186/s13075-022-02781-2. Arthritis Res Ther. 2022. PMID: 35526074 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical